Sat, 29 Mar 2025

Sat, 29 Mar 2025 Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

  >>


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025